The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Celecoxib as adjunctive therapy in schizophrenia: A double-blind, randomized and placebo-controlled trial
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Positive and Negative Syndrome Scale (PANSS) for schizophrenia.
Kay, S. R., Fiszbein, A., & Opler, L. A. (1987) · Schizophrenia Bulletin · doi:10.1093/schbul/13.2.261 · Cited by 21,378
(2001) · Journal of Obstetrics and Gynaecology Research · doi:10.1111/j.1447-0756.2001.tb01222.x · Cited by 3,461
Ethical principles for medical research involving human subjects
(2003) · Manual for Research Ethics Committees · doi:10.1017/cbo9780511550089.027 · Cited by 2,585
Jablensky, A., Sartorius, N., Ernberg, G., Anker, M., Korten, A., Cooper, J. E., Day, R., & Bertelsen, A. (1992) · Psychological Medicine. Monograph Supplement · doi:10.1017/s0264180100000904 · Cited by 1,769
Cytokines and the Brain: Implications for Clinical Psychiatry
Kronfol, Z., & Remick, D. G. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.5.683 · Cited by 784
Cyclo-Oxygenase-2 Gene Expression in Neurons Contributes to Ischemic Brain Damage
Nogawa, S., Zhang, F., Ross, M. E., & Iadecola, C. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-08-02746.1997 · Cited by 716
Müller, N., Riedel, M., Scheppach, C., Brandstätter, B., Sokullu, S., Krampe, K., Ulmschneider, M., Engel, R. R., Möller, H.-J., & Schwarz, M. J. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.6.1029 · Cited by 388
Schizophrenia: the fundamental questions
Andreasen, N. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(99)00027-2 · Cited by 312
Psychoneuroimmunology and the cytokine action in the CNS: Implications for psychiatric disorders
Müller, N., & Ackenheil, M. (1998) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(97)00179-6 · Cited by 306
Baik, E. J., Kim, E. J., Lee, S. H., & Moon, C.-H. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01797-7 · Cited by 200
Elevated CSF levels of interleukin-2 in neuroleptic-free schizophrenic patients
(1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.9.1408 · Cited by 185
The role of immune function in schizophrenia: an overview
Müller, N., Riedel, M., Ackenheil, M., & Schwarz, M. J. (1999) · European Archives of Psychiatry and Clinical Neurosciences · doi:10.1007/pl00014187 · Cited by 158
M�ller, N., Ulmschneider, M., Scheppach, C., Schwarz, M., Ackenheil, M., M�ller, H.-J., Gruber, R., & Riedel, M. J. (2004) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-004-0478-1 · Cited by 143
Autoimmunity in Schizophrenia: A Review of Recent Findings
Ganguli, R., Brar, J. S., Chengappa, K. N. R., Yang, Z. W., Nimgaonkar, V. L., & Rabin, B. S. (1993) · Annals of Medicine · doi:10.3109/07853899309147317 · Cited by 141
Celecoxib Augmentation of Continuously Ill Patients with Schizophrenia
Rapaport, M. H., Delrahim, K. K., Bresee, C. J., Maddux, R. E., Ahmadpour, O. A., & Dolnak, D. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.02.024 · Cited by 137
Müller, N., Empl, M., Riedel, M. J., Schwarz, M., & Ackenheil, M. (1997) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf02922260 · Cited by 127
Schizophrenia: a purinergic hypothesis
Lara, D. R., & Souza, D. O. (2000) · Medical Hypotheses · doi:10.1054/mehy.1999.0003 · Cited by 111
Cyclooxygenases in the Central Nervous System: Implications for Treatment of Neurological Disorders
Yermakova, A., & O’Banion, M. K. (2000) · Current Pharmaceutical Design · doi:10.2174/1381612003398672 · Cited by 93
Cytokine production in drug-free and neuroleptic-treated schizophrenic patients
Bessler, H., Levental, Z., Karp, L., Modai, I., Djaldetti, M., & Weizman, A. (1995) · Biological Psychiatry · doi:10.1016/0006-3223(94)00299-i · Cited by 86
Körschenhausen, D. A., Hampel, H. J., Ackenheil, M., Penning, R., & Müller, N. (1996) · Schizophrenia Research · doi:10.1016/0920-9964(95)00073-9 · Cited by 86
Cytokine profiles in drug-naive schizophrenic patients
Cazzullo, C. L., Sacchetti, E., Galluzzo, A., Panariello, A., Colombo, F., Zagliani, A., & Clerici, M. (2001) · Schizophrenia Research · doi:10.1016/s0920-9964(00)00046-3 · Cited by 80
Increased interleukin-1 and interleukin-3 like activity in schizophrenic patients
Sirota, P. (1995) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(94)00106-r · Cited by 64
The 5-HT hypothesis of schizophrenia.
Akhondzadeh, S. (2001) · PubMed · Cited by 63
Self-citationPharmacotherapy of Schizophrenia: The Past, Present and Future
Akhondzadeh, S. (2006) · Current Drug Therapy · doi:10.2174/157488506775268461 · Cited by 22
Self-citationThe glutamate hypothesis of schizophrenia
Akhondzadeh, S. (1998) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1046/j.1365-2710.1998.00160.x · Cited by 18
Self-citation
Cited by
Meta-Analysis of Cytokine Alterations in Schizophrenia: Clinical Status and Antipsychotic Effects
Miller, B. J., Buckley, P., Seabolt, W., Mellor, A., & Kirkpatrick, B. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.04.013 · Cited by 1,742
Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment
Khandaker, G. M., Cousins, L., Deakin, J., Lennox, B. R., Yolken, R., & Jones, P. B. (2015) · The Lancet Psychiatry · doi:10.1016/s2215-0366(14)00122-9 · Cited by 926
Inflammation in schizophrenia: pathogenetic aspects and therapeutic considerations.
Müller, N. (2018) · Schizophrenia Bulletin · doi:10.1093/schbul/sby024 · Cited by 648
Fillman, S. G., Cloonan, N., Catts, V. S., Miller, L. C., Wong, J., McCrossin, T., Cairns, M., & Weickert, C. S. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.110 · Cited by 609
Miyamoto, S., Miyake, N., Jarskog, L. F., Fleischhacker, W. W., & Lieberman, J. A. (2012) · Molecular Psychiatry · doi:10.1038/mp.2012.47 · Cited by 573
Metadata
- Authors
- AKHONDZADEH, S., TABATABAEE, M., AMINI, H., AHMADIABHARI, S., ABBASI, S., & BEHNAM, B.
- Venue
- Schizophrenia Research
- Publisher
- Elsevier BV
- Published
- 2007-02
- Volume
- 90
- Issue
- 1-3
- Pages
- 179-185
- ISSN
- 0920-9964 (ISSN-L)
- OpenAlex
- W2036194983
- Cited by
- 289
- References
- 25
- FWCI
- 10.19
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.